| Phase 3 validation of early detection biomarker panel for pancreatic cancer |
Ann Oberg |
Mayo Clinic |
PLCO |
Feb 2, 2017 |
2016-0041 |
| Compliance and Mortality |
Paul Pinsky |
NCI |
PLCO |
Feb 2, 2017 |
PLCO-255 |
| Melanoma Data Analysis2 |
Hovig Devejian |
FSU |
PLCO |
Jan 24, 2017 |
PLCO-253 |
| Request for access to the Ovarian Biomarkers data in order to correlate values with those obtained on our multiplex platform |
Amy Skubitz |
University of Minnesota |
PLCO |
Jan 20, 2017 |
PLCO-254 |
| Absolute Risk Model Evaluation and Integration of Imaging Biomarkers for Early Detection and Risk Assessment of Cancer |
Jae Lee |
Moffitt Cancer Center |
PLCO |
Jan 12, 2017 |
PLCO-248 |
| Examining Trends in Prostate Cancer Diagnosis, Treatment and Mortality |
D. Duane Baldwin |
Loma Linda University Health |
PLCO |
Jan 12, 2017 |
PLCO-247 |
| Diet and risk of glioma in the PLCO Study |
Ai-Seon Kuan |
Cancer Epidemiology Unit, University of Oxford |
PLCO |
Jan 5, 2017 |
PLCO-252 |
| Lifestyle changes after a cancer diagnosis in relation to all-cause and cancer-specific mortality |
Hannah Brooke |
Karolinska Institutet |
PLCO |
Dec 16, 2016 |
PLCO-245 |
| Diabetes, PSA levels and prostate cancer screening outcomes |
Eric Miller |
NCI |
PLCO |
Dec 12, 2016 |
PLCO-246 |
| Data mining based decision support system using data warehouse. |
Canan Eren ATAY |
Dokuz Eylül University |
PLCO |
Dec 5, 2016 |
PLCO-241 |
| Intelligent System based on Artificial Neural Networks to prostate cancer diagnosis |
Carlos Eduardo Ocrospoma Sarasi |
UNMSM |
PLCO |
Dec 2, 2016 |
PLCO-242 |
| Assessment of Recurrent status, Tissue and DNA Core availability and Prostate pathology section status among men in the PLCO |
Scott Kelly |
National Cancer Institute, NIH |
PLCO |
Dec 1, 2016 |
PLCO-243 |
| One carbon metabolism and endometrial cancer risk |
Britton Trabert |
NIH |
PLCO |
Nov 22, 2016 |
2016-0049 |
| Incorporating Biomarkers to Improve Lung Cancer Risk Prediction |
Ziding Feng |
UT MD Anderson Cancer Center |
PLCO |
Nov 9, 2016 |
PLCO-239 |
| Predictors of successful polypectomy |
Heather Yeo |
NewYork-Presbyterian/Weill Cornell Medicine |
PLCO |
Oct 28, 2016 |
PLCO-240 |
| Modification of Ovarian, Endometrial, Colorectal, and Breast Cancer risks associated with Oral Contraceptive use |
Kara Michels |
Division of Cancer Epidemiology and Genetics, National Cancer Institute |
PLCO |
Oct 28, 2016 |
PLCO-238 |
| Survival analysis of ovarian cancer using control group in PLCO |
John van Nagell |
University of Kentucky |
PLCO |
Oct 21, 2016 |
PLCO-237 |
| Machine learning-based approaches for risk calculation |
Alex Bui |
UCLA |
PLCO |
Oct 11, 2016 |
PLCO-235 |
| The association between meat and meat-related compounds intake and colorectal cancer incidence |
Arash Etemadi |
National Cancer Institute |
PLCO |
Oct 11, 2016 |
PLCO-236 |
| The Development of a Medical Ontology for Data Mining to classify, predict, and treat cancer subtypes in the PLCO population |
Jinglu Wang |
Weill Cornell Medical College |
PLCO |
Oct 7, 2016 |
PLCO-233 |
